CPDDN_PhaseI_DemyelinatingChildren_Follow-up_3years
Networks
-
Variables
-
Population
CPDDN - Phase I (Demyelinating Children)
The population is composed of Canadian children aged younger than 16 years who presented acquired demyelinating syndrome (ADS), to any of the 16 paediatric health-care facilities or seven regional health-care facilities in Canada and were enrolled within 90 days of symptom onset.
Data Collection Event
CPDDN - Phase I (Demyelinating Children) - Follow-up 3 years
Information was collected from participants and/or guardian through interviews which collected information about medications, smoke exposure, travel history, family, education. Additionally, questionnaires were used to collect the KIDSCREEN, PedsQL, and MSQoL54 (in MS children). Clinicians provided information on medication usage, episodes, and conducted a neurological exam.
MRI data were also collected.
Blood was collected for serum, DNA and PBMCs.